Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Isetta

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Reumatologia|March 12, 2021
Back to the future: identification and classification of polymyalgia rheumatica and polymyalgia rheumatica-like syndromes following cancer immunotherapy with checkpoint inhibitorsCiro Manzo, Marco Isetta
Reumatismo|March 4, 2025
After what time interval are we justified to diagnose immune checkpoint inhibitor-mediated polymyalgia rheumatica?Ciro Manzo, Marco Isetta
Life (Basel, Switzerland)|June 28, 2023
Absence of Long-Lasting Morning Stiffness at the Time of Diagnosis as Paraneoplastic Warning in Patients with Polymyalgia Rheumatica (PMR): Data from Italian Single-Center StudyCiro Manzo, Alberto Castagna, Marco Isetta
Reumatologia|July 5, 2022
Polymyalgia rheumatica and polymyalgia-like syndromes as adverse events following COVID-19 vaccines: working notes from a narrative review of published literatureCiro Manzo, Alberto Castagna, Marco Isetta
Reumatologia|December 16, 2024
Infective agents and polymyalgia rheumatica: key discussion points emerging from a narrative review of published literatureCiro Manzo, Marco Isetta, Alberto Castagna
Neurosci|September 22, 2025
Catatonia in Systemic Lupus ErythematosusCiro Manzo, Jordi Serra-Mestres, Marco Isetta
Rheumatology (Oxford, England)|July 24, 2021
Comment on: Comorbidities (excluding lymphoma) in Sjögren's syndromeCiro Manzo, Jordi Serra-Mestres, Marco Isetta
Medicines (Basel, Switzerland)|November 6, 2020
Identification and Classification of Polymyalgia Rheumatica (PMR) and PMR-Like Syndromes Following Immune Checkpoint Inhibitors (ICIs) Therapy: Discussion Points and Grey Areas Emerging from a Systematic Review of Published LiteratureCiro Manzo, Marco Isetta, Maria Natale, et al.
Medical Sciences (Basel, Switzerland)|April 23, 2025
Polymyalgia Rheumatica (PMR) and Polymyalgia Rheumatica-like (PMR-like) Manifestations in Cancer Patients Following Treatment with Nivolumab and Pembrolizumab: Methodological Blurred Points Identified Through a Systematic Review of Published Case ReportsCiro Manzo, Marco Isetta, Alberto Castagna, et al.
Reumatologia|November 16, 2023
Polymyalgia rheumatica and polymyalgia-like syndromes as adverse events following immunisation with COVID-19 vaccines: a 15 months updateCiro Manzo, Alberto Castagna, Arvind Nune, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Reumatologia|March 12, 2021
Back to the future: identification and classification of polymyalgia rheumatica and polymyalgia rheumatica-like syndromes following cancer immunotherapy with checkpoint inhibitorsCiro Manzo, Marco Isetta
Reumatismo|March 4, 2025
After what time interval are we justified to diagnose immune checkpoint inhibitor-mediated polymyalgia rheumatica?Ciro Manzo, Marco Isetta
Life (Basel, Switzerland)|June 28, 2023
Absence of Long-Lasting Morning Stiffness at the Time of Diagnosis as Paraneoplastic Warning in Patients with Polymyalgia Rheumatica (PMR): Data from Italian Single-Center StudyCiro Manzo, Alberto Castagna, Marco Isetta
Reumatologia|July 5, 2022
Polymyalgia rheumatica and polymyalgia-like syndromes as adverse events following COVID-19 vaccines: working notes from a narrative review of published literatureCiro Manzo, Alberto Castagna, Marco Isetta
Reumatologia|December 16, 2024
Infective agents and polymyalgia rheumatica: key discussion points emerging from a narrative review of published literatureCiro Manzo, Marco Isetta, Alberto Castagna
Neurosci|September 22, 2025
Catatonia in Systemic Lupus ErythematosusCiro Manzo, Jordi Serra-Mestres, Marco Isetta
Rheumatology (Oxford, England)|July 24, 2021
Comment on: Comorbidities (excluding lymphoma) in Sjögren's syndromeCiro Manzo, Jordi Serra-Mestres, Marco Isetta
Medicines (Basel, Switzerland)|November 6, 2020
Identification and Classification of Polymyalgia Rheumatica (PMR) and PMR-Like Syndromes Following Immune Checkpoint Inhibitors (ICIs) Therapy: Discussion Points and Grey Areas Emerging from a Systematic Review of Published LiteratureCiro Manzo, Marco Isetta, Maria Natale, et al.
Medical Sciences (Basel, Switzerland)|April 23, 2025
Polymyalgia Rheumatica (PMR) and Polymyalgia Rheumatica-like (PMR-like) Manifestations in Cancer Patients Following Treatment with Nivolumab and Pembrolizumab: Methodological Blurred Points Identified Through a Systematic Review of Published Case ReportsCiro Manzo, Marco Isetta, Alberto Castagna, et al.
Reumatologia|November 16, 2023
Polymyalgia rheumatica and polymyalgia-like syndromes as adverse events following immunisation with COVID-19 vaccines: a 15 months updateCiro Manzo, Alberto Castagna, Arvind Nune, et al.
Pageof 3